Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

WDFY1 Inhibitors

WDFY1 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the WDFY1 protein, a member of the WD repeat and FYVE domain-containing protein family. WDFY1 is known for its role in mediating protein-protein interactions through its WD40 repeat domains and binding to phosphoinositides via its FYVE domain. The protein plays an important role in cellular processes related to endosomal sorting and autophagy, particularly in the recognition and transport of cargo within cells. WDFY1 is involved in coordinating the assembly of complexes that facilitate the trafficking of proteins to specific cellular compartments, such as endosomes, which are critical for maintaining proper cellular function. By inhibiting WDFY1, these compounds interfere with its ability to organize and regulate the complexes involved in endosomal dynamics and autophagy.

The mechanism of WDFY1 inhibitors involves binding to its WD40 repeat domains or FYVE domain, preventing WDFY1 from interacting with its target proteins or binding to membrane phosphoinositides. This inhibition disrupts the assembly of protein complexes required for endosomal sorting and autophagic processes, potentially leading to alterations in cellular trafficking and degradation pathways. Researchers utilize WDFY1 inhibitors to explore the specific roles this protein plays in managing intracellular transport and autophagy. By blocking WDFY1 function, these inhibitors provide insight into how disruptions in cargo recognition and protein sorting can affect broader cellular processes, such as protein degradation, cellular signaling, and homeostasis. Studying these inhibitors allows for a deeper understanding of the molecular mechanisms governing vesicle trafficking and how WDFY1 contributes to maintaining the balance and efficiency of these processes within cells.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, a kinase upstream of many signaling pathways, including those that may involve WDFY1.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Another PI3K inhibitor that can alter the signaling cascade in which WDFY1 might participate.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, a downstream target of PI3K signaling, potentially affecting WDFY1-related processes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAP kinase, which might intersect with WDFY1-related signaling pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that can modify the activity of pathways that could indirectly modulate WDFY1 function.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, affecting the MAPK/ERK pathway, which could be linked to WDFY1's role in cellular processes.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Another MEK inhibitor that can attenuate the MAPK/ERK pathway, potentially affecting WDFY1-related activities.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can impact protein degradation pathways, possibly influencing WDFY1-related proteins.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Inhibits V-ATPase, affecting autophagic processes and potentially WDFY1's role in vesicular trafficking.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$65.00
$261.00
113
(3)

Autophagy inhibitor that can affect cellular recycling pathways, where WDFY1 might be involved.